Fig. 3.
Everolimus inhibits mTORC1 but activates ERK pathway in K-Ras mt PDAC cells. Everolimus treated or untreated K-Ras wt and mt PDAC cell lines, as indicated on the top of the panel, were examined by western blotting using antibodies to the unphosphorylated and phosphorylated (p-) proteins in the mTORC1 (A) and Raf-ERK pathway (B), as indicated to the left of the panel.